Thumbnail Image
Publication

Comorbidities in ADHD children treated with methylphenidate: a database study.

Kraut, Angela A
; 
Langner, Ingo
; 
Lindemann, Christina
; 
Banaschewski, Tobias
; 
Petermann, Ulrike
; 
Petermann, Franz
; 
Mikolajczyk, Rafael
; 
Garbe, Edeltraut
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2013
Submitted date
Show all metadata
Files
Thumbnail Image
Open Access publication
Adobe PDF, 346.91 KB
Other Titles
Abstract
Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorder (ADHD) in children. Treatment with MPH is contraindicated in the presence of certain psychiatric, cerebro- and cardiovascular conditions. We assessed MPH treatment prevalence and incidence and the frequency of comorbid conditions related to these contraindications in new MPH users compared to a control group without ADHD and ADHD medication.
Citation
Comorbidities in ADHD children treated with methylphenidate: a database study. 2013, 13:11 BMC Psychiatry
Affiliation
Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Publisher
Journal
BMC psychiatry
URI
http://hdl.handle.net/10033/288595
DOI
10.1186/1471-244X-13-11
PubMed ID
23294623
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1471-244X
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Archived with thanks to BMC psychiatry
Collections
Publications of the AG (ESME)